NCT04103892 · Interventional trial
A Study of CLE-100 (Oral Esketamine) in Addition to Standard Antidepressant Drug for Major Depressive Disorder - CLEO Study
Overall registry status Completed
Phase 2
Conditions Adjunctive Treatment of Major Depressive Disorder
Delaware Valley sites
- Clinical Site 101 · Marlton, NJ · Burlington County
- Clinical Site 106 · Media, PA · Delaware County
- Clinical Site 118 · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory